The Relationship of Leptin Levels with Lipid Profile and Cardiovascular Disease Risk Factors in Obese Individuals
Öz
Aims: This study was conducted as a systematic literature review to evaluate the effects of leptin hormone on lipid profile and cardiovascular disease (CVD) risk factors in obese individuals. Leptin is an adipokine playing a key role in energy balance and metabolic processes, and its serum levels are significantly increased in obesity. The hypothesis that increased leptin levels may negatively affect cardiovascular risk factors by contributing to dyslipidemia was investigated.
Methods: PubMed, Scopus, and Web of Science databases were searched for studies published between January 2010 and October 2023. Eighteen studies meeting the inclusion criteria were analyzed. Data were collected to assess the associations between leptin levels and lipid profile parameters (total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides) and cardiovascular risk factors, such as markers of inflammation, blood pressure (BP), and insulin resistance (IR).
Results: Positive and statistically significant associations were found between leptin levels and total cholesterol (r=0.45, p<0.001) and LDL-cholesterol (r=0.47, p<0.001). In addition, leptin levels were positively correlated with triglyceride levels (r=0.35, p<0.01) and negatively correlated with HDL-cholesterol levels (r=-0.30, p<0.01). Positive relationships were also found between leptin and markers of inflammation; for example, a significant correlation (r=0.42, p<0.001) was observed between leptin and C-reactive protein (CRP). There was a tendency for increased BP and IR with increasing leptin levels.
Conclusion: Increased leptin levels in obese individuals have negative effects on lipid profiles and increase CVD risk factors. A positive correlation has been observed between leptin and LDL cholesterol, but the causal relationship has not been conclusively established. Furthermore, leptin may accelerate the development of atherosclerosis by increasing markers of inflammation. These findings suggest that leptin may be a potential biomarker in the assessment of obesity-related cardiovascular risks. Leptin-targeted therapeutic approaches and strategies to overcome leptin resistance may be important in the management of obesity and related cardiometabolic disorders.
Anahtar Kelimeler
Leptin, Obesity, Lipid Profile, Cardiovascular Disease, Dislipidemia, Insülin Resistance, inflammation
Etik Beyan
Araştırma literatür taramasıdır.
Teşekkür
Akademik ingilizce çeviri desteği sağlayan Nexus tercüme teşekkür ederim.
Kaynakça
- 1. World Health Organization (WHO). Obesity and overweight. 2021. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
- 2. Nguyen DM, El-Serag HB. The epidemiology of obesity. Gastroenterol Clin North Am. 2010;39(1):1-7.
- 3. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083-1096.
- 4. Zhang Y, Liu J, Yao J, et al. Obesity: pathophysiology and intervention. Nutr. 2018;20(9):866-873.
- 5. Ahima RS, Flier JS. Leptin and the neuroendocrinology of fasting and starvation. Annu Rev Physiol. 2000;62:413-437.
- 6. Myers MG, Leibel RL, Seeley RJ, Schwartz MW. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab. 2010;21(11):643–651.
- 7. National Cholesterol Education Program (NCEP). Third report... (Adult Treatment Panel III) Final report. Circulation. 2002;106(25):3143-3421.
- 8. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk... Circulation. 1999;100(13):1481-1492.
- 9. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881-887.
- 10. Oda E, Kawai R, Aizawa Y. Association between serum leptin concentrations and C-reactive protein. Clin Endocrinol (Oxf). 2008;69(6):1099-1104.